Endocrinology focuses on hormonal system and metabolic health. Learn about the diagnosis and treatment of diabetes, thyroid disorders, and adrenal conditions.
Send us all your questions or requests, and our expert team will assist you.
The overview and definition of hyperparathyroidism provides a clear picture of a hormonal disorder that affects calcium balance in the body. This page is designed for international patients and healthcare professionals seeking detailed information about the condition, its impact, and the state‑of‑the‑art care available at Liv Hospital. Did you know that up to 1% of the adult population may develop hyperparathyroidism, often without obvious symptoms? Understanding the disease early can prevent complications such as kidney stones, bone loss, and cardiovascular issues. In the following sections we will explore the underlying mechanisms, clinical presentation, diagnostic pathways, and therapeutic options, delivering a thorough overview and definition that empowers you to make informed health decisions.
Liv Hospital’s multidisciplinary team combines expertise in endocrinology, surgery, and nutrition to offer personalized treatment plans for patients from around the globe. Whether you are newly diagnosed or looking for a second opinion, this comprehensive guide will help you navigate the journey from diagnosis to long‑term management.
Hyperparathyroidism is a condition characterized by excessive production of parathyroid hormone (PTH) by the parathyroid glands, leading to elevated calcium levels in the blood. The overview and definition of this disorder includes three main categories, each with distinct causes and clinical implications.
Each type requires a tailored diagnostic and therapeutic approach. Primary hyperparathyroidism is the most common form in the United States and Europe, while secondary forms are prevalent among patients with renal insufficiency. Recognizing the specific type is essential for effective management.
Identifying the root causes of hyperparathyroidism helps clinicians develop preventive strategies and targeted therapies. Below is a concise list of the most frequently encountered etiologies and associated risk factors.
Environmental factors such as low dietary calcium intake and certain medications (e.g., lithium) may also contribute. Understanding these risk elements allows patients and physicians to implement lifestyle modifications and monitoring protocols that can mitigate disease progression.
Hyperparathyroidism often presents subtly, making an accurate overview and definition of its clinical spectrum vital for early detection. Symptoms can be grouped into skeletal, renal, gastrointestinal, and neuropsychiatric categories.
Diagnostic evaluation integrates laboratory tests and imaging:
At Liv Hospital, our endocrinology team utilizes high‑resolution imaging and state‑of‑the‑art laboratory assays to ensure precise diagnosis, forming the foundation for an effective treatment plan.
Therapeutic decisions are guided by the specific type of hyperparathyroidism, severity of hypercalcemia, symptom burden, and patient comorbidities. Below is a structured overview of the main treatment modalities.
Post‑treatment surveillance includes periodic serum calcium, PTH, and renal function tests, as well as bone density assessments. Patients who undergo surgery are typically re‑evaluated at 6 months and then annually.
Liv Hospital’s multidisciplinary approach ensures that surgical candidates receive care from experienced endocrine surgeons, while medical patients benefit from personalized pharmacologic regimens and regular monitoring.
Beyond medical treatment, lifestyle adjustments play a pivotal role in maintaining optimal calcium balance and preventing complications. The following recommendations are part of a comprehensive overview and definition of long‑term management.
Patients traveling to Istanbul for care can rely on Liv Hospital’s 360‑degree international patient services, which include interpreter assistance, transportation coordination, and comfortable accommodation options, ensuring a seamless treatment experience.
Liv Hospital is a JCI‑accredited private facility in Istanbul dedicated to serving international patients with world‑class endocrine care. Our team combines expertise in advanced imaging, minimally invasive surgery, and personalized medical therapy, all supported by comprehensive patient services that handle appointments, travel logistics, and language support. Choosing Liv Hospital means accessing cutting‑edge treatment in a culturally sensitive environment, backed by a commitment to safety and clinical excellence.
Ready to take control of your health? Contact Liv Hospital today to schedule a consultation with our endocrine specialists and begin a personalized treatment plan for hyperparathyroidism.
Experience seamless international care, expert guidance, and the confidence of being treated at a globally recognized medical center.
Liv Hospital Ulus
Assoc. Prof. MD. Seda Turgut
Endocrinology and Metabolism
Liv Hospital Ulus
Prof. MD. Demet Yetkin
Endocrinology and Metabolism
Liv Hospital Vadistanbul
Prof. MD. Berçem Ayçiçek
Endocrinology and Metabolism
Liv Hospital Vadistanbul
Prof. MD. Gönül Çatlı
Pediatric Endocrinology
Liv Hospital Vadistanbul
Prof. MD. Kubilay Ükinç
Endocrinology and Metabolism
Liv Hospital Bahçeşehir
Assoc. Prof. MD. Sevil Arı Yuca
Pediatric Endocrinology and Metabolic Diseases
Liv Hospital Bahçeşehir
Assoc. Prof. MD. Ufuk Özuğuz
Endocrinology and Metabolism
Liv Hospital Bahçeşehir
Spec. MD. Hüseyin Çelik
Endocrinology and Metabolism
Liv Hospital Topkapı
Prof. MD. Mehmet Aşık
Endocrinology and Metabolism
Liv Hospital Topkapı
Prof. MD. Nujen Çolak Bozkurt
Endocrinology and Metabolism
Liv Hospital Ankara
Prof. MD. Banu Aktaş Yılmaz
Endocrinology and Metabolism
Liv Hospital Ankara
Prof. MD. Peyami Cinaz
Pediatric Endocrinology
Liv Hospital Ankara
Prof. MD. Serdar Güler
Endocrinology and Metabolism
Liv Hospital Ankara
Spec. MD. Elif Sevil Alagüney
Endocrinology and Metabolism
Liv Hospital Gaziantep
Prof. MD. Zeynel Beyhan
Endocrinology and Metabolic Diseases
Liv Hospital Gaziantep
Spec. MD. Tahsin Özenmiş
Endocrinology and Metabolism
Liv Hospital Samsun
Assoc. Prof. MD. Gülçin Cengiz Ecemiş
Endocrinology and Metabolism
Liv Hospital Samsun
Spec. MD. Esra Tutal
Endocrinology and Metabolic Diseases
Liv Bona Dea Hospital Bakü
MD. FİDAN QULU
Endocrinology and Metabolism
Spec. MD. Zümrüt Kocabey Sütçü
Pediatric Endocrinology
Liv Hospital Ulus + Liv Hospital Vadistanbul + Liv Hospital Topkapı
Prof. MD. Cengiz Kara
Pediatric Endocrinology
Send us all your questions or requests, and our expert team will assist you.
Hyperparathyroidism occurs when one or more of the four parathyroid glands secrete excessive parathyroid hormone (PTH). PTH regulates calcium and phosphate balance; its overproduction raises calcium in the bloodstream. The condition can be primary, caused by a gland adenoma or hyperplasia, secondary, resulting from chronic kidney disease or vitamin D deficiency, or tertiary, where prolonged secondary disease leads to autonomous gland function. Elevated calcium may be asymptomatic initially but can cause bone loss, kidney stones, and cardiovascular issues if left untreated.
Primary hyperparathyroidism is usually due to a benign tumor (adenoma) or hyperplasia of the parathyroid tissue, leading to high PTH and calcium levels. Secondary hyperparathyroidism is a compensatory response to low calcium, often caused by chronic kidney disease or vitamin D deficiency, resulting in low calcium but elevated PTH. Tertiary hyperparathyroidism develops after long‑standing secondary disease, where the glands become autonomous and continue to secrete PTH despite normalized calcium levels, often requiring surgical intervention.
Key causes include genetic predispositions such as familial isolated hyperparathyroidism and MEN syndromes. Chronic kidney disease reduces phosphate excretion, stimulating PTH release, while vitamin D deficiency limits calcium absorption, both leading to secondary disease. Prior neck radiation can damage parathyroid tissue. Risk rises with age, and women are slightly more affected than men. Lifestyle factors like low dietary calcium and drugs such as lithium may also contribute, highlighting the importance of preventive monitoring.
Patients may experience skeletal issues (bone pain, fractures, osteitis fibrosa cystica), renal manifestations (calcium kidney stones), neuropsychiatric effects (fatigue, depression), gastrointestinal complaints (nausea, constipation), and cardiovascular problems (hypertension, arrhythmias). Diagnosis begins with serum calcium and PTH measurements—elevated calcium with inappropriately high PTH suggests primary disease. Vitamin D levels, renal function tests, and imaging (neck ultrasound, sestamibi scan, 4D‑CT) localize abnormal glands. Liv Hospital employs high‑resolution imaging and advanced labs for accurate assessment.
For primary hyperparathyroidism, minimally invasive parathyroidectomy is the definitive cure, often guided by intra‑operative PTH monitoring. In tertiary disease, subtotal or total parathyroidectomy with autotransplantation may be needed. Medical management is useful for secondary and tertiary cases: calcimimetics like cinacalcet lower PTH secretion; bisphosphonates reduce bone resorption; aggressive hydration and diuretics manage acute hypercalcemia; vitamin D supplementation corrects deficiency. Ongoing monitoring of calcium, PTH, renal function, and bone density is essential post‑treatment.
After parathyroidectomy, patients are typically re‑evaluated at six months to confirm normalization of calcium and PTH levels, followed by yearly assessments. Monitoring includes serum calcium, PTH, renal function, and dual‑energy X‑ray absorptiometry (DEXA) scans to track bone health. Any persistent or recurrent hypercalcemia may prompt further imaging. Liv Hospital’s multidisciplinary team coordinates these follow‑ups, ensuring timely detection of complications and adjustment of any adjunct medical therapy.
Patients should aim for 1,000–1,200 mg of calcium daily from food, avoid excessive calcium supplements unless prescribed, and stay well‑hydrated (2–3 L of water per day) to reduce stone risk. Weight‑bearing activities strengthen bone density. Annual laboratory tests and bone density scans help track disease activity. Consistent medication adherence, especially for calcimimetics or vitamin D analogs, is crucial. Liv Hospital also offers international patient services—interpretation, travel coordination, and accommodation—to facilitate seamless care for those traveling to Istanbul.
BlogDiabetes MellitusMay 14, 2026Understand what is glucose plasma, its normal range, and why fasting plasma glucose tests are the simplest,...
BlogDiabetes MellitusMay 14, 2026We explain what is an insulin injection kit used for, detailing its role in insulin therapy to support diab...
BlogDiabetes MellitusMay 14, 2026We explain what gland produces insulin and how it balances blood sugar with hormones like insulin, glucagon...
BlogDiabetes MellitusMay 14, 2026Understand what causes type 1 diabetes, including autoimmune triggers and environmental factors, with insig...
BlogEndocrinologyMay 14, 2026We provide clear insights on delayed puberty male, its common causes, and compassionate treatment to suppor...
BlogEndocrinologyMay 14, 2026Learn about the cause of hashimoto thyroid disease, including genetic and environmental factors. We provide...
Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.
Start Chat on WhatsApp or call us at +90 530 174 26 75